Skip to main content
Top
Published in: Journal of Nephrology 2/2023

20-09-2022 | Peritonitis | original Article

Incremental peritoneal dialysis allows to reduce the time spent for dialysis, glucose exposure, economic cost, plastic waste and water consumption

Authors: Luca Nardelli, Antonio Scalamogna, Elisa Cicero, Giuseppe Castellano

Published in: Journal of Nephrology | Issue 2/2023

Login to get access

Abstract

Background

Incremental peritoneal dialysis (incPD) as the initial PD strategy represents a convenient and resource-sparing approach, but its impact on patient, healthcare and environment has not been thoroughly evaluated.

Methods

This study includes 147 patients who started incPD at our institution between 1st January, 2009 and 31st December, 2021. Adequacy measures, peritoneal permeability parameters, peritonitis episodes, hospitalizations and increase in CAPD dose prescriptions were recorded. The savings related to cost, patient glucose exposure, time needed to perform dialysis, plastic waste, and water usage were compared to full-dose PD treatment.

Results

During the study follow-up 11.9% of the patients transitioned from incremental to full dose PD. Patient cumulative probability of remaining on PD at 12, 24, 36, 48 and 60 months was 87.6, 65.4, 46.1, 30.1 and 17.5%, respectively. The median transition time from 1 to 2 exchanges, from 2 to 3 and 3 to 4 exchanges were 5, 9 and 11.8 months, respectively. Compared to full dose PD, 1, 2, and 3 exchanges per day led to reduction in glucose exposure of 20.4, 14.8 or 8.3 kg/patient-year, free lifetime gain of 18.1, 13.1 or 7.4 day/patient-year, a decrease in cost of 8700, 6300 or 3540 €/patient-year, a reduction in plastic waste of 139.2, 100.8 or 56.6 kg/patient-year, and a decline in water use of 25,056, 18,144 or 10,196 L/patient-year.

Conclusions

In comparison with full-dose PD, incPD allows to reduce the time spent for managing dialysis, glucose exposure, economic cost, plastic waste, and water consumption.

Graphical abstract

Literature
1.
go back to reference (2021) United States Renal Data System: 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. In: https://adr.usrds.org/2021. Accessed 1 Feb 2022 (2021) United States Renal Data System: 2021 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. In: https://​adr.​usrds.​org/​2021. Accessed 1 Feb 2022
2.
go back to reference Nardelli L, Scalamogna A, Messa P et al (2022) Peritoneal dialysis for potential kidney transplant recipients: pride or prejudice ? Medicina (Kaunas) 58:214CrossRefPubMed Nardelli L, Scalamogna A, Messa P et al (2022) Peritoneal dialysis for potential kidney transplant recipients: pride or prejudice ? Medicina (Kaunas) 58:214CrossRefPubMed
3.
go back to reference Nardelli L, Scalamogna A, Gallieni M et al (2021) Is peritoneal dialysis the first-choice renal replacement therapy for patients waiting for a kidney transplant? G Ital Nefrol 38:2021-vol6PubMed Nardelli L, Scalamogna A, Gallieni M et al (2021) Is peritoneal dialysis the first-choice renal replacement therapy for patients waiting for a kidney transplant? G Ital Nefrol 38:2021-vol6PubMed
4.
go back to reference Liyanage T, Ninomiya T, Jha V et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982CrossRefPubMed Liyanage T, Ninomiya T, Jha V et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982CrossRefPubMed
6.
go back to reference Piccoli GB, Cupisti A, Aucella F et al (2020) Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology. J Nephrol 33:681–698CrossRefPubMedCentralPubMed Piccoli GB, Cupisti A, Aucella F et al (2020) Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology. J Nephrol 33:681–698CrossRefPubMedCentralPubMed
7.
go back to reference Guest S, Leypoldt JK, Cassin M et al (2017) Kinetic modeling of incremental ambulatory peritoneal dialysis exchanges. Perit Dial Int 37:205–211CrossRefPubMed Guest S, Leypoldt JK, Cassin M et al (2017) Kinetic modeling of incremental ambulatory peritoneal dialysis exchanges. Perit Dial Int 37:205–211CrossRefPubMed
8.
go back to reference Nolph KD (1998) Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 13:117–119CrossRefPubMed Nolph KD (1998) Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 13:117–119CrossRefPubMed
9.
go back to reference de Vecchi A, Scalamogna A, Finazzi S et al (2000) Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int 20:412–417CrossRefPubMed de Vecchi A, Scalamogna A, Finazzi S et al (2000) Preliminary evaluation of incremental peritoneal dialysis in 25 patients. Perit Dial Int 20:412–417CrossRefPubMed
10.
go back to reference Burkart JM, Satko SG (2000) Incremental initiation of dialysis: one center’s experience over a two year period. Perit Dial Int 20:418–422CrossRefPubMed Burkart JM, Satko SG (2000) Incremental initiation of dialysis: one center’s experience over a two year period. Perit Dial Int 20:418–422CrossRefPubMed
11.
13.
go back to reference Lee SM, Min YS, Ki Y et al (2021) Comparison of clinical outcome between incremental peritoneal dialysis and conventional peritoneal dialysis: a propensity score matching study. Ren Fail 43:1222–1228CrossRefPubMedCentralPubMed Lee SM, Min YS, Ki Y et al (2021) Comparison of clinical outcome between incremental peritoneal dialysis and conventional peritoneal dialysis: a propensity score matching study. Ren Fail 43:1222–1228CrossRefPubMedCentralPubMed
14.
go back to reference Lee Y, Chung SW, Park S et al (2019) Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci Rep 9:10105CrossRefPubMedCentralPubMed Lee Y, Chung SW, Park S et al (2019) Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci Rep 9:10105CrossRefPubMedCentralPubMed
15.
go back to reference Yan H, Fang W, Lin A et al (2017) Three versus 4 daily exchanges and residual kidney function decline in incident CAPD patients: a randomized controlled trial. Am J Kidney Dis 69:506–513CrossRefPubMed Yan H, Fang W, Lin A et al (2017) Three versus 4 daily exchanges and residual kidney function decline in incident CAPD patients: a randomized controlled trial. Am J Kidney Dis 69:506–513CrossRefPubMed
16.
go back to reference Agar JWM, Barraclough KA (2020) Water use in dialysis: environmental considerations. Nat Rev Nephrol 16:556–557CrossRefPubMed Agar JWM, Barraclough KA (2020) Water use in dialysis: environmental considerations. Nat Rev Nephrol 16:556–557CrossRefPubMed
18.
go back to reference La Milia V, Cabiddu G, Virga G et al (2017) Peritoneal equilibration test reference values using a 3.86% glucose solution during the first year of peritoneal dialysis: results of a multicenter study of a large patient population. Perit Dial Int 37:633–638CrossRefPubMed La Milia V, Cabiddu G, Virga G et al (2017) Peritoneal equilibration test reference values using a 3.86% glucose solution during the first year of peritoneal dialysis: results of a multicenter study of a large patient population. Perit Dial Int 37:633–638CrossRefPubMed
19.
go back to reference Li PK, Chow KM, Cho Y et al (2022) ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 42:110–153CrossRefPubMed Li PK, Chow KM, Cho Y et al (2022) ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 42:110–153CrossRefPubMed
20.
go back to reference Nardelli L, Scalamogna A, Pisati S, Gallieni M (2021) Urgent-start PD: a viable approach. G Ital Nefrol 2:n°7 Nardelli L, Scalamogna A, Pisati S, Gallieni M (2021) Urgent-start PD: a viable approach. G Ital Nefrol 2:n°7
21.
go back to reference Scalamogna A, Nardelli L, Zanoni F, Messa P (2020) Double purse-string around the inner cuff of the peritoneal catheter: a novel technique for an immediate initiation of continuous peritoneal dialysis. Int J Artif Organs 43:365–371CrossRefPubMed Scalamogna A, Nardelli L, Zanoni F, Messa P (2020) Double purse-string around the inner cuff of the peritoneal catheter: a novel technique for an immediate initiation of continuous peritoneal dialysis. Int J Artif Organs 43:365–371CrossRefPubMed
22.
go back to reference Nardelli L, Scalamogna A, Messa P (2021) The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients. J Nephrol 34:493–501CrossRefPubMed Nardelli L, Scalamogna A, Messa P (2021) The impact of the superficial cuff position on the exit site and tunnel infections in CAPD patients. J Nephrol 34:493–501CrossRefPubMed
23.
go back to reference Scalamogna A, Nardelli L, Cicero E, Castellano G (2022) Analysis of mechanical complications in urgent-start peritoneal dialysis. J Nephrol 35:1489–1496 (Online ahead of print) Scalamogna A, Nardelli L, Cicero E, Castellano G (2022) Analysis of mechanical complications in urgent-start peritoneal dialysis. J Nephrol 35:1489–1496 (Online ahead of print)
24.
go back to reference Bodnar DM, Busch S, Fuchs J et al (1993) Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests. Adv Perit Dial 9:114–118PubMed Bodnar DM, Busch S, Fuchs J et al (1993) Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests. Adv Perit Dial 9:114–118PubMed
25.
go back to reference Berlich R, Canaud B, Renner S et al (2019) Plastic waste reduction in different peritoneal dialysis strategies: the impact of disposable choice on carbon footprint. Nephrol Dial Transplant 34(suppl 1):gf106.FP573 Berlich R, Canaud B, Renner S et al (2019) Plastic waste reduction in different peritoneal dialysis strategies: the impact of disposable choice on carbon footprint. Nephrol Dial Transplant 34(suppl 1):gf106.FP573
26.
go back to reference Marinangeli G, Neri L, Viglino G et al (2018) PD in Italy: the 5th GSDP-SIN Census 2014. G Ital Nefrol 35:vol5 Marinangeli G, Neri L, Viglino G et al (2018) PD in Italy: the 5th GSDP-SIN Census 2014. G Ital Nefrol 35:vol5
27.
go back to reference Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed
28.
go back to reference Grodstein GP, Blumenkrantz MJ, Kopple JD et al (1981) Glucose absorption during continuous ambulatory peritoneal dialysis. Kid Int 19:564–567CrossRef Grodstein GP, Blumenkrantz MJ, Kopple JD et al (1981) Glucose absorption during continuous ambulatory peritoneal dialysis. Kid Int 19:564–567CrossRef
29.
go back to reference Law S, Davenport A (2020) Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients. Br J Nutr 123:1269–1276CrossRefPubMed Law S, Davenport A (2020) Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients. Br J Nutr 123:1269–1276CrossRefPubMed
30.
go back to reference Lambie M, Chess J, Do J et al (2016) Peritoneal dialysate glucose load and systemic glucose metabolism in non- diabetics: results from the GLOBAL Fluid cohort study. PLoS ONE 11:e0155564CrossRefPubMedCentralPubMed Lambie M, Chess J, Do J et al (2016) Peritoneal dialysate glucose load and systemic glucose metabolism in non- diabetics: results from the GLOBAL Fluid cohort study. PLoS ONE 11:e0155564CrossRefPubMedCentralPubMed
31.
go back to reference Li PKT, Culleton BF, Ariza A et al (2013) Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 23:1889–1900CrossRef Li PKT, Culleton BF, Ariza A et al (2013) Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 23:1889–1900CrossRef
32.
go back to reference Szeto C, Edin F, Chow K, Uk M (2007) New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 49:524–532CrossRefPubMed Szeto C, Edin F, Chow K, Uk M (2007) New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 49:524–532CrossRefPubMed
33.
go back to reference Jiang N, Lin A, Axelsson J (2008) Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26:423–428CrossRefPubMed Jiang N, Lin A, Axelsson J (2008) Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease. Blood Purif 26:423–428CrossRefPubMed
34.
go back to reference Law S, Davenport A (2021) The effect of glucose absorption from peritoneal dialysates on changes in lipid profiles in prevalent peritoneal dialysis patients. Perit Dial Int 41:115–117CrossRefPubMed Law S, Davenport A (2021) The effect of glucose absorption from peritoneal dialysates on changes in lipid profiles in prevalent peritoneal dialysis patients. Perit Dial Int 41:115–117CrossRefPubMed
35.
go back to reference Martikainen T, Carola AT, Ekstrand A (2005) Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients. Blood Purif 23:303–310CrossRefPubMed Martikainen T, Carola AT, Ekstrand A (2005) Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients. Blood Purif 23:303–310CrossRefPubMed
36.
go back to reference Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046–1051CrossRefPubMed Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046–1051CrossRefPubMed
37.
go back to reference Htay H, Cho Y, Pascoe EM et al (2017) Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ Trial. Perit Dial Int 37:283–289CrossRefPubMed Htay H, Cho Y, Pascoe EM et al (2017) Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ Trial. Perit Dial Int 37:283–289CrossRefPubMed
38.
go back to reference Hoenich NA, Levin R, Pearce C (2005) Clinical waste generation from renal units: implications and solutions. Semin Dial 18:396–400CrossRefPubMed Hoenich NA, Levin R, Pearce C (2005) Clinical waste generation from renal units: implications and solutions. Semin Dial 18:396–400CrossRefPubMed
40.
go back to reference Yan H, Abreu Z, Bargman JM (2021) Incremental peritoneal dialysis in incident end-stage kidney disease patients. Perit Dial Int 42:387–393 (Online ahead of print)CrossRefPubMed Yan H, Abreu Z, Bargman JM (2021) Incremental peritoneal dialysis in incident end-stage kidney disease patients. Perit Dial Int 42:387–393 (Online ahead of print)CrossRefPubMed
41.
go back to reference Cho H, Kim MH, Kim HJ et al (2017) Development and validation of the modified charlson comorbidity index in incident peritoneal dialysis patients: a national population-based approach. Perit Dial Int 37:94–102CrossRefPubMed Cho H, Kim MH, Kim HJ et al (2017) Development and validation of the modified charlson comorbidity index in incident peritoneal dialysis patients: a national population-based approach. Perit Dial Int 37:94–102CrossRefPubMed
Metadata
Title
Incremental peritoneal dialysis allows to reduce the time spent for dialysis, glucose exposure, economic cost, plastic waste and water consumption
Authors
Luca Nardelli
Antonio Scalamogna
Elisa Cicero
Giuseppe Castellano
Publication date
20-09-2022
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2023
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-022-01433-7

Other articles of this Issue 2/2023

Journal of Nephrology 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.